gastro-oesophageal junction
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-oesophageal junction adenocarcinoma
... Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a[r] ...
10
The Impact of Clinical Features on Efficacy and Safety of the Combination of Ramucirumab and Paclitaxel for Metastatic Gastro-Oesophageal Junction/ Gastric Cancer: Data of a Real Life Experience in an Italian Institution
... previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a 303. double-blind, randomised Phase 3 trial[r] ...
13
Oesophagectomy rates and post resection outcomes in patients with cancer of the oesophagus and gastro oesophageal junction: a population based study using linked health administrative linked data
... the gastro-oesophageal junction did not alter the trends established with that of oesophageal can- cer ...in oesophageal cancer alone became significant in the over- all ...
10
Emerging aspects of oesophageal and gastro oesophageal junction cancer histopathology – an update for the surgical oncologist
... and gastro-oesophageal junction are rapidly increasing in incidence and have a well described sequence of carcinogenesis: the Barrett's metaplasia-dysplasia- adenocarcinoma ...the ...
16
Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction
... to recognize that surgery within the ST03 trial was sub- ject to a number of other significant changes in practice. The trial was undertaken during the time of reconfigura- tion of surgical services for ...
13
Minimal residual disease in cancer of the oesophagus and gastro oesophageal junction
... for oesophageal or gastro-oesophageal cancer between January 1990 and September 2002 were identified from the prospectively compiled upper gastrointestinal cancer database at this ...
130
Nasogastric tube depth: The 'NEX' guideline is incorrect
... Confirmation of gastric position is key to detecting misplacement, albeit after trauma may have occurred. UK National Patient Safety Association (NPSA) recommend pH and X-ray for first and second-line confirmation, ...
26
Congenital oesophageal hiatal hernia in a pug
... incision and the abdominal wall incision were apposed with a single layer of simple continuous sutures using 2 metric polydioxanone (PDS; Ethicon). Completion of the gastropexy procedure resulted in sufficient caudal ...
5
Gastro oesophageal reflux disease : studies in physiology and innovations in surgical management
... er oesophageal sphincter pressure is unchanged, it is possible that the plications placed by the TEP m ethod m ay form a plateau w hich allow s the LOS to function better and to reduce both the volum e and ...
184
Impact of gastro-oesophageal reflux on microRNA expression, location and function
... the oesophageal squamous mucosa 5 cm above the gastro-oesophageal junction from normal subjects and from subjects with gastro-oesophageal reflux with ulcerative ...of ...
9
Caspase cleaved cytokeratin 18 and tumour regression in gastro oesophageal adenocarcinomas treated with neoadjuvant chemotherapy
... tric/gastro-oesophageal junction adenocarcinomas and 45.5% of lower third oesophageal adenocarcinomas had TRG 1, 2 or 3 compared to ...
6
New emerging targets in cancer immunotherapy: the role of LAG3
... CHT, chemotherapy; GEJ, gastro-oesophageal junction; HNSCC, squamous head and neck cancer; HR, hormone receptor; IDO, indoleamine (2,3)-dioxygenase; LAG3, lymphocyte-assoiated gene 3; M[r] ...
6
A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma
... staging oesophageal cancer, 13 for gastric cancer, and four for cancers at the gastro-oesophageal ...For gastro-oesophageal T staging, including cancers at the gastro- ...
7
Clinical utility of ramucirumab in advanced gastric cancer
... Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a[r] ...
13
<p>Current Molecular Targeted Agents for Advanced Gastric Cancer</p>
... Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an internation[r] ...
14
Original Article The efficacy of molecular targeted agents in the treatment of gastroesophageal junction cancer: a systematic review and meta-analysis
... [14] Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Pas- salacqua R, Goswami C, Safran H, dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, ...
6
Electrical stimulation for gastroesophageal reflux disease: current state of the art
... Notes: GERD-HRQL deteriorated after cessation of PPI and improved significantly at 3 and 6 months after start of electrical stimulation therapy, as compared to baseline values while on and off PPI. Data are presented as ...
9
Management of Gastroesophageal Reflux Disease and Hiatus Hernia: Overview and Authors' Perspective
... lower oesophageal sphincter pressure, increasing ...and oesophageal pH with manometry demonstrated reflux during smoking in two-thirds of participants; one-third of all recorded reflux episodes throughout ...
8
Comparison of oesophageal function tests between Chinese non-erosive reflux disease and reflux hypersensitivity patients
... as oesophageal hypocontractility, is a manometric pattern characterised by ineffective swal- lows with poor bolus transit in the distal ...24-h oesophageal pH-metry, regardless of the presence of defective ...
7
Assessment on patients health related quality of life associated with gerd
... 4. Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009; 58:174-181. doi: ...
6